Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0118
0,0000
BRL/USD 0,1928
0,0000
INR/USD 0,0105
0,0000
CNY/USD 0,1476
0,0000
ZAR/USD 0,0618
0,0000
IDR/USD 0,0001
0,0000
SPACE FOR MEDIA DIPLOMACY
01:15 «BRICSterview»
01:15 «BRICSterview»
Now 16+
01:15

«BRICSterview»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
01:45 «BRICSdialogue»
Next
01:45

«BRICSdialogue»

16+
02:15

«Laboratorium»

16+
02:30

«Lеt's be clear»

16+
Menu
Broadcast «BRICSterview»
RUB/USD
0,0118
0,0000
BRL/USD
0,1928
0,0000
INR/USD
0,0105
0,0000
CNY/USD
0,1476
0,0000
ZAR/USD
0,0618
0,0000
IDR/USD
0,0001
0,0000
TV BRICS Apps
Russian scientists develop new medicine

It is an antibacterial drug for the treatment of complicated infections


The development of Russian scientists is intended for the treatment of bacterial infections caused by antibiotic-resistant microorganisms.

Studies have shown a favourable safety profile as well as high efficacy of the drug. The medicine should help in cases of antimicrobial resistance.

Resistance to antimicrobial drugs is a biological phenomenon that occurs when microbes, such as bacteria and fungi, acquire the ability to defeat drugs designed to kill them. This is reported by Prensa Latina, a partner of TV BRICS.

According to the Ministry of Health, the drug is intended for the treatment of bacterial infections and is effective against antibiotic-resistant bacteria, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae.

Photo: iStock